UBS AM’s Generate Biomedicines GENB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.61K Buy
+174
New +$2.68K ﹤0.01% 4003

Other funds holding GENB

UBS AM's GENB Position: Q3 2026 in Review

UBS AM opened a new position in Generate Biomedicines (GENB) in Q3 2026: 174 shares worth $2.61K. The stake represents ﹤0.01% of the portfolio and ranks #4003 among its holdings.

86 funds tracked by Wall St. Rank hold GENB as of Q3 2026.

  • UBS AM held 174 shares of Generate Biomedicines worth $2.61K as of Q3 2026.
  • Generate Biomedicines was a new UBS AM position in Q3 2026.
  • Generate Biomedicines made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4003 holding.
  • 86 funds tracked by Wall St. Rank held Generate Biomedicines as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.